Clinical Trial Update: Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety, preliminary efficacy, and pharmacokinetics of isatuximab alone or with atezolizumab in advanced malignancies; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Atezolizumab (atezolizumab)
• Isatuximab (isatuximab)

Snippet

Sponsor: Sanofi | Conditions: Neoplasm | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-06-08